| Trial ID: | L7032 |
| Source ID: | NCT00367445
|
| Associated Drug: |
Inhaled Human Insulin (Exubera)
|
| Title: |
A Clinical Trial Comparing Short-Term Efficacy and Safety of Exubera and Lantus
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: Inhaled Human Insulin (Exubera)|DRUG: Insulin Glargine (Lantus)
|
| Outcome Measures: |
Primary: Variability of blood glucose over a period of 72 hours | Secondary: Insulin pharmacokinetics
|
| Sponsor/Collaborators: |
Sponsor: Pfizer
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
30
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2006-09
|
| Completion Date: |
2007-02
|
| Results First Posted: |
|
| Last Update Posted: |
2008-01-29
|
| Locations: |
Pfizer Investigational Site, Chula Vista, California, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00367445
|
